A Canadian Cost-Utility Analysis of 2 Trabecular Microbypass Stents at Time of Cataract Surgery in Patients with Mild to Moderate Open-Angle Glaucoma

Abstract

PURPOSE: To assess, from the Canadian public payer perspective, the cost-utility of implanting iStent Inject trabecular bypass stent (TBS) devices in conjunction with cataract surgery versus cataract surgery alone in patients with open-angle glaucoma (OAG) and visually significant cataract. DESIGN: Cost-utility analysis using efficacy and safety results of pivotal randomized clinical trial.

Authors

Ahmed IIK; Podbielski DW; Patel V; Falvey H; Murray J; Botteman M; Goeree R

Journal

Ophthalmology Glaucoma, Vol. 3, No. 2, pp. 103–113

Publisher

Elsevier

Publication Date

March 2020

DOI

10.1016/j.ogla.2019.11.009

ISSN

2589-4234

Associated Experts

Ron Goeree

Professor Emeritus, Faculty of Health Sciences

Visit profile

Labels